The DOI matches its Crossref record; 133 of the 135 references it cites were found in a registry or an index.
Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes
Open accessAbstract
The incidence and prevalence of diabetes mellitus (DM) continue to grow dramatically throughout the world, due primarily to the increase in type 2 DM (T2DM). Although improvements in DM and hypertension management have reduced the proportion of diabetic individuals who develop chronic kidney disease (CKD) and progress to end-stage renal disease (ESRD), the sheer increase in people developing DM will have a major impact on dialysis and transplant needs. This KDIGO conference addressed a number of controversial areas in the management of DM patients with CKD, including aspects of screening for CKD with measurements of albuminuria and estimated glomerular filtration rate (eGFR); defining treatment outcomes; glycemic management in both those developing CKD and those with ESRD; hypertension goals and management, including blockers of the renin-angiotensin-aldosterone system; and lipid management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The absence of effect modification by baseline albuminuria contrasts with the findings from trials of RAS blockade.[31][32][33]”
From SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis (2019) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Diabetes management may be particularly challenging in individuals with chronic kidney disease who may be at an increased risk of hypoglycemia and in whom HbA 1c can be falsely low (276)”
From The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2021) · cites this paper as [276]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447068 · Cited by 11,782
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Flagged first, then by citations
2 of the 135 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Kidney Disease: Improving Global Outcomes (KDIGO) Lipid Work Group, 2013, KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease, Kindey Int Suppl, 3, 259
Cited by
Sorted by citations
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Wanner, C., Inzucchi, S. E., Lachin, J. M., Fitchett, D., von Eynatten, M., Mattheus, M., Johansen, O. E., Woerle, H. J., Broedl, U. C., & Zinman, B. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1515920 · Cited by 3,655
Self-citationLiraglutide and renal outcomes in type 2 diabetes
Mann, J. F. E., Ørsted, D. D., Brown-Frandsen, K., Marso, S. P., Poulter, N. R., Rasmussen, S., Tornøe, K., Zinman, B., & Buse, J. B. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1616011 · Cited by 1,253
Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014
Afkarian, M., Zelnick, L. R., Hall, Y. N., Heagerty, P. J., Tuttle, K., Weiss, N. S., & de Boer, I. H. (2016) · JAMA · doi:10.1001/jama.2016.10924 · Cited by 1,026
Neuen, B. L., Young, T., Heerspink, H. J. L., Neal, B., Perkovic, V., Billot, L., Mahaffey, K. W., Charytan, D. M., Wheeler, D. C., Arnott, C., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30256-6 · Cited by 893
Self-citationHolt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetes Care · doi:10.2337/dci21-0043 · Cited by 699
Mosenzon, O., Wiviott, S. D., Cahn, A., Rozenberg, A., Yanuv, I., Goodrich, E. L., Murphy, S. A., Heerspink, H. J. L., Zelniker, T. A., Dwyer, J. P., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30180-9 · Cited by 684
The role of the complement system in diabetic nephropathy
Flyvbjerg, A. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.31 · Cited by 397
Self-citationHolt, R. I. G., DeVries, J. H., Fischl, A. H., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, É., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05568-3 · Cited by 470
Tang, G., Li, S., Zhang, C., Chen, H., Wang, N., & Feng, Y. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.12.020 · Cited by 372
Yang, D., Wang, M., Zhang, C., & Wang, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1359255 · Cited by 356
Jiang, W., Wang, J., Shen, X., Lu, W., Wang, Y., Li, W., Gao, Z., Xu, J., Li, X., Liu, R., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1897 · Cited by 234
AGE/RAGE in diabetic kidney disease and ageing kidney
Wu, X., Zhang, D., Wang, Y., Tan, Y.-Q., Yu, X.-Y., & Zhao, Y. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.025 · Cited by 241
Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets
Toth‐Manikowski, S. M., & Atta, M. G. (2015) · Journal of Diabetes Research · doi:10.1155/2015/697010 · Cited by 203
Bonner, R., Albajrami, O., Hudspeth, J. C., & Upadhyay, A. (2020) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2020.08.004 · Cited by 200
Cherney, D. Z. I., Lund, S. S., Perkins, B. A., Groop, P., Cooper, M. E., Kaspers, S., Pfarr, E., Woerle, H. J., & von Eynatten, M. (2016) · Diabetologia · doi:10.1007/s00125-016-4008-2 · Cited by 174
Management of diabetes mellitus in patients with chronic kidney disease
Hahr, A. J., & Molitch, M. E. (2015) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-015-0001-9 · Cited by 142
Self-citationOellgaard, J., Gæde, P., Rossing, P. R., Persson, F., Parving, H., & Pedersen, O. B. (2017) · Kidney International · doi:10.1016/j.kint.2016.11.023 · Cited by 119
Scirica, B. M., Mosenzon, O., Bhatt, D. L., Jacob, A. U., Steg, P. G., McGuire, D. K., Im, K., Kanevsky, E., Stahre, C., Sjöstrand, M., et al. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.4228 · Cited by 115
George, C., Echouffo-Tcheugui, J. B., Jaar, B. G., Okpechi, I. G., & Kengne, A. P. (2022) · BMC Medicine · doi:10.1186/s12916-022-02438-6 · Cited by 91
Liu, W. J., Gan, Y., Huang, W. F., Wu, H.-L., Zhang, X.-Q., Zheng, H. J., & Liu, H.-F. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-2002-6 · Cited by 88
Allen, A. O., Iqbal, Z., Green‐Saxena, A., Hurtado, M., Hoffman, J. L., Mao, Q., & Das, R. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002560 · Cited by 80
Improvements in the Management of Diabetic Nephropathy
Dounousi, E. C., Duni, Α., Leivaditis, K., Vaios, V., Eleftheriadis, T., & Liakopoulos, V. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.119 · Cited by 83
Kadowaki, T., Nangaku, M., Hantel, S., Okamura, T., von Eynatten, M., Wanner, C., & Koitka‐Weber, A. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12971 · Cited by 74
Self-citationStack, A. G., Dronamraju, N., PARKINSON, J. R., Johansson, S. A., JOHNSSON, E. K., Erlandsson, F., & Terkeltaub, R. A. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2020.09.009 · Cited by 73
The Landscape of Diabetic Kidney Disease in the United States
Duru, O. K., Middleton, T. R., Tewari, M. K., & Norris, K. C. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0980-x · Cited by 75
Dietary Fiber and Gut Microbiota in Renal Diets
Camerotto, C., Cupisti, A., D’Alessandro, C., Muzio, F., & Gallieni, M. A. (2019) · Nutrients · doi:10.3390/nu11092149 · Cited by 76
Diabetic Complications: An Update on Pathobiology and Therapeutic Strategies
Nellaiappan, K., Preeti, K., Khatri, D. K., & Singh, S. B. (2021) · Current Diabetes Reviews · doi:10.2174/1573399817666210309104203 · Cited by 79
Sharma, P., Hajam, Y. A., Kumar, R., & Rai, S. (2021) · Phytomedicine Plus · doi:10.1016/j.phyplu.2021.100188 · Cited by 74
Gao, P., Li, L., Liu, Y., Gui, D., Zhang, J., Han, J., Wang, J., Wang, N., Lu, J., Chen, S., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw2050 · Cited by 67
Ninčević, V., Kolarić, T. O., Roguljić, H., Kizivat, T., Smolić, M., & Bilić-Čurčić, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235831 · Cited by 71
Yang, S., Ma, C., Wu, H., zhang, H., Yuan, F., Yang, G., Yang, Q., Jia, L., Liang, Z., & Kang, L. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104678 · Cited by 66
Shen, Y., Chen, W., Han, L., Bian, Q., Fan, J., Cao, Z., Jin, X., Ding, T., Xian, Z., Guo, Z., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.07.002 · Cited by 63
The Role of Chemokines and Chemokine Receptors in Diabetic Nephropathy
Chang, T., & Chen, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093172 · Cited by 64
Ortíz, A., Ferro, C. J., Balafa, O. C., Burnier, M., Ekart, R., Halimi, J., Kreutz, R. H., Mark, P. B., Persu, A., Rossignol, P., et al. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab167 · Cited by 64
Is Bariatric Surgery an Effective Treatment for Type II Diabetic Kidney Disease?
Friedman, A. N., & Wolfe, B. M. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07670715 · Cited by 64
Wada, T., Hosoya, T., Honda, D., Sakamoto, R., Narita, K., Sasaki, T., Okui, D., & Kimura, K. (2018) · Clinical and Experimental Nephrology · doi:10.1007/s10157-018-1530-1 · Cited by 61
Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study
Brosnahan, G., Wang, W., Gitomer, B. Y., Struemph, T., George, D. M., You, Z., Nowak, K. L., Klawitter, J., & Chonchol, M. B. (2021) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.06.026 · Cited by 59
Role of intracellular complement activation in kidney fibrosis
Portilla, D., & Xavier, S. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15408 · Cited by 59
de Carvalho, C. M., Gross, L. A., de Azevedo, M. J., & Viana, L. V. (2019) · Nutrients · doi:10.3390/nu11020347 · Cited by 60
Sulaj, A., Kopf, S., von Rauchhaupt, E., Kliemank, E., Brune, M., Κender, Ζ., Bartl, H., Cortizo, F. G., Klepac, K., Han, Z., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac197 · Cited by 61
The outcomes of SGLT-2 inhibitor utilization in diabetic kidney transplant recipients
Sheu, J.-Y., Chang, L., Chen, J., Pan, H., Tseng, C., Chueh, S., & Wu, V. (2024) · Nature Communications · doi:10.1038/s41467-024-54171-8 · Cited by 63
Novel insights into the disease transcriptome of human diabetic glomeruli and tubulointerstitium
Levin, A., Reznichenko, A., Witasp, A., Liu, P., Greasley, P. J., Sorrentino, A., Blöndal, T., Zambrano, S. S., Nordström, J., Bruchfeld, A. N., et al. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa121 · Cited by 54
Li, G., Qin, Y., Qin, S.-L., Zhou, X., Zhao, W., & Zhang, D. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118269 · Cited by 54
Astragaloside IV ameliorates renal injury in db/db mice
Sun, H., Wang, W., Han, P., Shao, M., Song, G., Du, H., Yi, T., & Li, S. (2016) · Scientific Reports · doi:10.1038/srep32545 · Cited by 53
Urinary Metabolomic Profiling in Streptozotocin-Induced Diabetic Mice after Treatment with Losartan
Hyeon, J. S., Jung, Y., Lee, G.-Y., Ha, H., & Hwang, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238969 · Cited by 52
Jia, Z., Wang, K., Zhang, Y., Duan, Y., Xiao, K., Liu, S., & Ding, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.720387 · Cited by 52
Cui, C., Zang, N., Song, J. T., Guo, X., He, Q., Hu, H., Yang, M., Wang, Y., Yang, J., Zou, Y., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202200488r · Cited by 54
Vitamin D protects against diabetic nephropathy: Evidence-based effectiveness and mechanism
Hu, X., Liu, W., Yan, Y., Liu, H., Huang, Q., Xiao, Y., Gong, Z., & Du, J. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.09.037 · Cited by 52
Florijn, B. W., Duijs, J. M. G. J., Levels, J. H. M., Dallinga‐Thie, G. M., Wang, Y., Böing, A. N., Yuana, Y., Stam, W., Limpens, R. W. A. L., Au, Y. W., et al. (2019) · Diabetes · doi:10.2337/db18-1360 · Cited by 53
Mende, C. W. (2015) · Advances in Therapy · doi:10.1007/s12325-015-0272-7 · Cited by 51
Wan, E., Fong, D., Fung, C., Yu, E., Chin, W. Y., Chan, A. K. L., & Lam, C. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0671-x · Cited by 40
El-Samahy, M. H., Adly, A., Elhenawy, Y. I., Ismail, E. G. M., Pessar, S. A., Mowafy, M. E., Saad, M. S., & Mohammed, H. H. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.10.014 · Cited by 53
Clinical and pathological factors associated with progression of diabetic nephropathy
Liang, S., Cai, G., & Chen, X. (2017) · Nephrology · doi:10.1111/nep.13182 · Cited by 52
Li, X., Wen, J., Dong, Y., Zhang, Q., Guan, J., Liu, F., Zhou, T., Li, Z., Fan, Y., & Wang, N. (2021) · Cell Death and Disease · doi:10.1038/s41419-020-03377-x · Cited by 50
Oral Infections and Systemic Health - More than Just Links to Cardiovascular Diseases.
Meurman, J. H., & Martínez, A. B. (2021) · PubMed Central · doi:10.3290/j.ohpd.b1993965 · Cited by 49
The Burden of Diabetes-Related Chronic Kidney Disease in China From 1990 to 2019
Pan, X., Lin, X., Huang, X., Xu, J., Ye, L., Zhang, T., Hu, S., Jiang, H., Ren, Y., & Shan, P. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.892860 · Cited by 51
Sávio-Silva, C., Beyerstedt, S., Soinski-Sousa, P. E., Casaro, E. B., Balby-Rocha, M. T. A., Simplício-Filho, A., Alves-Silva, J., & Rangel, É. B. (2020) · Stem Cells International · doi:10.1155/2020/8833725 · Cited by 52
Dong, R., Yu, J., Yu, F., Yang, S., Qian, Q., & Zha, Y. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00071.2019 · Cited by 46
Role of local complement activation in kidney fibrosis and repair
Portilla, D., Sabapathy, V., & Chauss, D. (2025) · Journal of Clinical Investigation · doi:10.1172/jci188345 · Cited by 46
New Insights into the Use of Empagliflozin—A Comprehensive Review
Forycka, J., Hajdys, J., Krzemińska, J., Wilczopolski, P., Wronka, M., Młynarska, E., Rysz, J., & Franczyk, B. (2022) · Biomedicines · doi:10.3390/biomedicines10123294 · Cited by 52
Ying, A. F., Tang, T. Y., Jin, A., Chong, T. T., Hausenloy, D. J., & Koh, W. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01441-0 · Cited by 45
Wang, L., Wu, J., Cheng, J.-F., Liu, X.-Y., Ma, F., Guo, L., Xu, J.-M., Wu, T., Mohan, C., Peng, A., et al. (2015) · Journal of Nephrology · doi:10.1007/s40620-015-0183-3 · Cited by 45
Glycemic Control as Primary Prevention for Diabetic Kidney Disease
MacIsaac, R. J., Jerums, G., & Ekinci, E. I. (2018) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2017.11.003 · Cited by 43
Cooper, M. E., Inzucchi, S. E., Zinman, B., Hantel, S., von Eynatten, M., Wanner, C., & Koitka‐Weber, A. (2019) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.03.432 · Cited by 42
Self-citationEffects of the Soluble Guanylate Cyclase Stimulator Praliciguat in Diabetic Kidney Disease
Hanrahan, J. P., de Boer, I. H., Bakris, G. L., Wilson, P. J., WAKEFIELD, J. D., Seferović, J. P., Chickering, J. G., Chien, Y., Carlson, K. E., Cressman, M. D., et al. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08410520 · Cited by 44
Chen, X., Sun, L., Li, D., Lai, X., Wen, S., Chen, R., Zhang, Z., Li, Q., & Sun, S. (2022) · Food & Function · doi:10.1039/d1fo03615g · Cited by 40
Wu, X., Gao, Y., Xu, L., Zou, D., Zhu, Z., Wang, X., Yao, W., Luo, L., Tong, Y., Tian, N., et al. (2017) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x17500586 · Cited by 38
Yun, J., Ahn, Y., Song, K., Yoo, K., Kim, H.-W., Park, Y., & Ko, S. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.01.031 · Cited by 38
Pharmacological Activities of Plant‐Derived Fraxin with Molecular Mechanisms: A Comprehensive Review
Ferdous, J., Bhuia, M. S., Chowdhury, R., Rakib, A. I., Aktar, A., Hasan, M. S. A., Coutinho, H. D. M., & Islam, M. T. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202301615 · Cited by 36
Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 Trial
Scirica, B. M., Bohula, E. A., Dwyer, J. P., Qamar, A., Inzucchi, S. E., McGuire, D. K., KEECH, A. C., Smith, S. R., Murphy, S. A., Im, K., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.038341 · Cited by 35
Sivalingam, S., Wasehuus, V. S., Rotbain Curovic, V., Blond, M. B., Hansen, T. W., Persson, F., & Rossing, P. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15287 · Cited by 34
MDM 2 is implicated in high‐glucose‐induced podocyte mitotic catastrophe via Notch1 signalling
Tang, H., Lei, C., Ye, C., Gao, P., Wan, C., Chen, S., He, F.-F., Wang, Y., Su, H., & Zhang, C. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13253 · Cited by 35
Vascular Permeability: Regulation Pathways and Role in Kidney Diseases
Cai, A., Chatziantoniou, C., & Calmont, A. (2021) · The Nephron journals/Nephron journals · doi:10.1159/000514314 · Cited by 34
Management of diabetes mellitus in dialysis patients: Obstacles and challenges
Alalawi, F. J. A., & Bashier, A. M. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.05.007 · Cited by 34
Mechanisms of Herbal Nephroprotection in diabetes mellitus
Dragoș, D., Manea, M. M., Timofte, D., & Ionescu, D. (2020) · Journal of Diabetes Research · doi:10.1155/2020/5710513 · Cited by 32
Li, Q., Wen, F., Wang, Y., Li, S., Lin, S., Qi, C., Chen, Z., Qiu, X., Zhang, Y., Zhang, S., et al. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00952-5 · Cited by 38
Amod, A., Buse, J. B., McGuire, D. K., Pieber, T. R., Pop‐Busui, R., Pratley, R. E., Zinman, B., Hansen, M. B., Jia, T., Mark, T., et al. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-00715-x · Cited by 34
Ding, S., Qiu, H., Huang, J., Chen, R., Zhang, J., Huang, B., Zou, X., Cheng, O., & Jiang, Q. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.05.004 · Cited by 31
Zhou, K., Zi, X., Song, J., Zhao, Q., Liu, J., Bao, H., & Li, L. (2022) · Molecules · doi:10.3390/molecules27196221 · Cited by 30
Luo, Y., Zhang, L., & Zhao, T. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1193228 · Cited by 28
Managing diabetic kidney disease
Zac‐Varghese, S., & Winocour, P. H. (2017) · British Medical Bulletin · doi:10.1093/bmb/ldx047 · Cited by 28
Zheng, J., Jiang, Z., Chen, D., Wang, S., Zhao, W., & Li, L. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12934 · Cited by 27
Fibroblast Growth Factor 23 and Incident CKD in Type 2 Diabetes
Isakova, T., Craven, T. E., Lee, J. J., Scialla, J. J., Xie, H., WAHL, P. W., Marcovina, S. M., Byington, R. P., & Wolf, M. S. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06190614 · Cited by 28
Shen, H., & Wang, W. (2020) · Journal of Liposome Research · doi:10.1080/08982104.2020.1780607 · Cited by 27
Diet and Diabetic Kidney Disease: Plant Versus Animal Protein
Moorthi, R. N., Vorland, C. J., & Gallant, K. M. H. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0843-x · Cited by 29
Zhang, H., Yang, Y., Wang, Y., Wang, B., & Li, R. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s149298 · Cited by 27
Relationship between Macrophages and Tissue Microenvironments in Diabetic Kidneys
Yan, J., Li, X., Liu, N., He, C., & Zhong, Y. (2023) · Biomedicines · doi:10.3390/biomedicines11071889 · Cited by 30
Sodium glucose cotransporters inhibitors in type 1 diabetes
Dellepiane, S., Nasr, M. B., Assi, E., Usuelli, V., Letizia, T., D’Addio, F., Zuccotti, G., & Fiorina, P. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.04.018 · Cited by 26
Wang, Y., Yang, J. H., Chang, X., Xue, Y., Liu, G., Zhang, T., Chen, W., Fan, W., Tian, J., & Ren, X. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202400215 · Cited by 28
Elwakiel, A., Gupta, D., Rana, R., Manoharan, J., Al‐Dabet, M. M., Ambreen, S., Fatima, S., Zimmermann, S., Mathew, A., Li, Z., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52214-8 · Cited by 27
Shikata, K., Haneda, M., Ninomiya, T., Koya, D., Suzuki, Y., Suzuki, D., Ishida, H., Akai, H., Tomino, Y., Uzu, T., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13339 · Cited by 23
ASIAN PACIFIC SOCIETY OF NEPHROLOGY CLINICAL PRACTICE GUIDELINE ON DIABETIC KIDNEY DISEASE
Liew, A., Bavanandan, S., Prasad, N., Wong, M. G., Chang, J. M., Eiam‐Ong, S., Hao, C., Lim, C. Y., Lim, S. K., Oh, K., et al. (2020) · Nephrology · doi:10.1111/nep.13785 · Cited by 24
Hanna, R. M., Ferrey, A., Rhee, C. M., & Kalantar‐Zadeh, K. (2020) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2020.105461 · Cited by 27
Zhao, J., Mo, C., Ai, J., Shi, W., & LiFeng, M. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6109406 · Cited by 23
Abe, M., Okada, K., Maruyama, N., Takashima, H., Oikawa, O., & Soma, M. (2015) · Journal of Diabetes Research · doi:10.1155/2016/5374746 · Cited by 23
Store-operated calcium entry and diabetic complications
Chaudhari, S. K., & Ma, R. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215609693 · Cited by 22
Niclosamide ethanolamine improves diabetes and diabetic kidney disease in mice.
Han, P., Shao, M., Guo, L., Wang, W., Song, G., Yu, X., Zhang, C., Ge, N., Yi, T., Li, S., et al. (2018) · Europe PMC (PubMed Central) · Cited by 22
Association between red cell distribution width/serum albumin ratio and diabetic kidney disease
Chen, J., Zhang, D., Zhou, D., Dai, Z., & Wang, J. (2024) · Journal of Diabetes · doi:10.1111/1753-0407.13575 · Cited by 22
Li, H., Dong, A., Li, N., Ma, Y., Zhang, S., Deng, Y., Chen, S., & Zhang, M. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s395512 · Cited by 22
Kwon, Y., Lee, H. S., Park, G. E., & Lee, J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.863391 · Cited by 23
Metadata
- Authors
- Molitch, M. E., Adler, A. I., Flyvbjerg, A., Nelson, R. G., So, W.-Y., Wanner, C., Kasiske, B. L., Wheeler, D. C., de Zeeuw, D., & Mogensen, C. E.
- Affiliations
- Northwestern University (US)
- Addenbrooke's Hospital (GB)
- Aarhus University (DK)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- Chinese University of Hong Kong (HK)
- Universitätsklinikum Würzburg (DE)
- Hennepin County Medical Center (US)
- University College London (GB)
- Aarhus University Hospital (DK)
- Corresponding author
- Molitch, Mark E.
- ORCID
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 87
- Issue
- 1
- Pages
- 20-30
- ISSN
- 0085-2538 (ISSN-L)
- PMC
- PMC4214898
- OpenAlex
- W2136160292
- Semantic Scholar
- f2af4f6271bd70cd0bbaacb694a7a365a61dea86
- Cited by
- 268
- References
- 135
- Citations by year
- 2026: 18 · 2025: 17 · 2024: 20 · 2023: 17 · 2022: 24 · 2021: 31 · 2020: 34 · 2019: 22 · 2018: 26 · 2017: 23 · 2016: 15 · 2015: 15
- FWCI
- 15.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Kidney International (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- PubMed Central (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetic nephropathy, chronic kidney disease, type 2 diabetes, end-stage renal disease, albuminuria, estimated glomerular filtration rate, CKD screening, glycemic control, antihypertensive therapy, renin-angiotensin-aldosterone system inhibitors, lipid control, treatment outcomes
- MeSH terms
- Albuminuria, Diabetic Nephropathies, Humans, Hyperglycemia, Hypertension, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
